EUCTR2004-005069-39-IT进行中（未招募）不适用
A double-blind, randomised, multicenter, comparative study of escitalopram and duloxetine in outpatients with Major Depressive Disorder
DBECK ITALIA0 个研究点目标入组 260 人开始时间: 2005年11月4日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 260
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
A double-blind, randomised, multicenter, comparativestudy of escitalopram and duloxetine in outpatients withMajor Depressive DisorderEUCTR2004-005069-39-DEH. Lundbeck A/S260
进行中（未招募）
1 期
A double-blind, randomised, multicenter, comparativestudy of escitalopram and duloxetine in outpatients withMajor Depressive DisorderMajor depressive disorderEUCTR2004-005069-39-SEH. Lundbeck A/S260
进行中（未招募）
1 期
A double-blind, randomised, multicenter, comparative study of escitalopram and duloxetine in outpatients with Major Depressive DisorderMajor depressive disorderEUCTR2004-005069-39-CZH.Lundbeck A/S260
进行中（未招募）
1 期
A double-blind, randomised, multicenter, comparative study of escitalopram and duloxetine in outpatients with Major Depressive DisorderMajor depressive disorderEUCTR2004-005069-39-GBH. Lundbeck A/S260
进行中（未招募）
1 期
A multicentre, randomised, double-blind, comparative trial of a novel CCR5 antagonist, UK427,857, in combination with zidovudine/lamivudine versus efavirenz in combination with zidovudine/lamivudine for the treatment of antiretroviral-naïve HIV-1 infected subjectsK-427,857 is an antagonist of the human chemokine receptor, and is intended to help prevent the development and progression of AIDS in indivuduals HIV-1 positive.MedDRA version: 14.1 Level: PT Classification code 10020161 Term: HIV infection System Organ Class: 10021881 - Infections and infestationsEUCTR2004-001914-15-GBViiV Healthcare UK Limited891